{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T18:03:29Z","timestamp":1775066609132,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1124\/jpet.300.1.34","type":"journal-article","created":{"date-parts":[[2003,1,10]],"date-time":"2003-01-10T18:30:34Z","timestamp":1042223434000},"page":"34-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["The Potent Emetogenic Effects of the Endocannabinoid, 2-AG (2-Arachidonoylglycerol) Are Blocked by \u03949-Tetrahydrocannabinol and Other Cannnabinoids"],"prefix":"10.1016","volume":"300","author":[{"given":"Nissar A.","family":"Darmani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.300.1.34_bib1","doi-asserted-by":"crossref","first-page":"9902","DOI":"10.1074\/jbc.271.17.9902","article-title":"(\u2212)-\u03949-Tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylate cyclase.","volume":"271","author":"Bayewitch","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.300.1.34_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/bbrc.1999.0254","article-title":"Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.","volume":"256","author":"Bisogno","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.300.1.34_bib3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0022-3565(24)38906-2","article-title":"Cannabinoid agonist signal transduction in rat brain: comparison of cannabinoid agonists in receptor binding, G-protein activation, and adenyl cyclase inhibition.","volume":"295","author":"Breivogel","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.300.1.34_bib4","doi-asserted-by":"crossref","first-page":"16865","DOI":"10.1074\/jbc.273.27.16865","article-title":"Cannabinoid receptor agonist efficacy for stimulating [35S]GTP\u03b3S binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity.","volume":"273","author":"Breivogel","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.300.1.34_bib5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0893-133X(00)00197-4","article-title":"\u03949-Tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB1 receptor antagonist\/inverse agonist SR 141716A.","volume":"24","author":"Darmani","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.300.1.34_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0091-3057(01)00531-7","article-title":"\u03949-Tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB1 receptors in the least shrew.","volume":"69","author":"Darmani","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.300.1.34_bib7","doi-asserted-by":"crossref","unstructured":"Darmani NA. The CB1 cannabinoid antagonist inverse agonist reverses the antiemetic and motor depressant actions of WIN 55,212-2 in the least shrew (in press), (2001c)","DOI":"10.1016\/S0014-2999(01)01355-3"},{"key":"10.1124\/jpet.300.1.34_bib8","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s007020050118","article-title":"Serotonin 5-HT3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis.","volume":"105","author":"Darmani","year":"1998","journal-title":"J Neural Transm"},{"key":"10.1124\/jpet.300.1.34_bib9","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s007020070043","article-title":"Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice.","volume":"107","author":"Darmani","year":"2000","journal-title":"J Neural Transmission"},{"key":"10.1124\/jpet.300.1.34_bib10","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s007020050222","article-title":"The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew).","volume":"106","author":"Darmani","year":"1999","journal-title":"J Neural Transm"},{"key":"10.1124\/jpet.300.1.34_bib11","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor.","volume":"258","author":"Devane","year":"1992","journal-title":"Science (Wash DC)"},{"key":"10.1124\/jpet.300.1.34_bib12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0165-6147(96)01017-6","article-title":"A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes.","volume":"18","author":"Fr\u00f6lich","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.300.1.34_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0009-3084(00)00193-6","article-title":"The endocannabinoid system: a physiological perspective on its role in psychomotor control.","volume":"108","author":"Giuffrida","year":"2000","journal-title":"Chem Phys Lipids"},{"key":"10.1124\/jpet.300.1.34_bib14","series-title":"Marijuana and Medicine","first-page":"599","article-title":"Cannabinoids and the control of chemotherapy-induced nausea and vomiting","author":"Gralla","year":"1999"},{"key":"10.1124\/jpet.300.1.34_bib15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0022-3565(24)37418-X","article-title":"Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5\u2032-O-(3-[35S]thio)triphosphate binding assay in rat cerebellar membranes.","volume":"285","author":"Griffin","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.300.1.34_bib16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study.","volume":"11","author":"Herkenham","year":"1991","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.300.1.34_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0090-6980(00)00051-4","article-title":"Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol.","volume":"61","author":"Hillard","year":"2000","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1124\/jpet.300.1.34_bib18","doi-asserted-by":"crossref","first-page":"33744","DOI":"10.1074\/jbc.M007088200","article-title":"Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2.","volume":"275","author":"Kozak","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.300.1.34_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s004410000261","article-title":"Localization of CB1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system.","volume":"302","author":"Kulkarni-Narla","year":"2000","journal-title":"Cell Tissue Res"},{"key":"10.1124\/jpet.300.1.34_bib20","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0026-895X(25)13215-X","article-title":"Anandamide, an endogenous cannabinoid, inhibits calcium currents as partial agonists in N18 neuroblastoma cells.","volume":"44","author":"Mackie","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.300.1.34_bib21","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0306-4522(92)90409-U","article-title":"Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry.","volume":"48","author":"Mailleux","year":"1992","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.300.1.34_bib22","first-page":"A563","article-title":"Functional assessment of cannabinoid receptors in human gut motility.","volume":"15","author":"Manara","year":"2001","journal-title":"FASEB J"},{"key":"10.1124\/jpet.300.1.34_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.300.1.34_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0079-6468(08)70037-7","article-title":"Towards cannabinoid drugs revisited.","volume":"35","author":"Mechoulam","year":"1998","journal-title":"Prog Med Chem"},{"key":"10.1124\/jpet.300.1.34_bib25","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/BF00978372","article-title":"Distribution of indolamines and [3H]paraoxetine binding in rat brain regions following acute or perinatal \u03949-tetrahydrocannabinoid treatments.","volume":"18","author":"Molina-Holgado","year":"1993","journal-title":"Neurochem Res"},{"key":"10.1124\/jpet.300.1.34_bib26","first-page":"12","article-title":"Cannabis and cannabinoids: pharmacology and rationale for clinical use.","volume":"3","author":"Pertwee","year":"1999","journal-title":"Forsch Komplem"},{"key":"10.1124\/jpet.300.1.34_bib27","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/gut.48.6.859","article-title":"Cannabinoids and the gastrointestinal tract.","volume":"48","author":"Pertwee","year":"2001","journal-title":"Gut"},{"key":"10.1124\/jpet.300.1.34_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0014-2999(00)00044-3","article-title":"Activational role of cannabinoids on movement.","volume":"391","author":"Sa\u00f1udo-Pe\u00f1a","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.300.1.34_bib29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0024-3205(99)00293-3","article-title":"Motor actions of cannabinoids in the basal ganglia output nuclei.","volume":"65","author":"Sa\u00f1udo-Pe\u00f1a","year":"1999","journal-title":"Life Sci"},{"key":"10.1124\/jpet.300.1.34_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0026-895X(24)23149-7","article-title":"\u03949-Tetrahycrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture.","volume":"55","author":"Shen","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.300.1.34_bib31","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1523\/JNEUROSCI.16-14-04322.1996","article-title":"Cannabinoid receptor agonists inhibit glutameric synaptic transmission in rat hippocampal cultures.","volume":"16","author":"Shen","year":"1996","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.300.1.34_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.300.1.34_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0009-3084(00)00189-4","article-title":"2-Arachidonoylglycerol and the cannabinoid receptors.","volume":"108","author":"Sugiura","year":"2000","journal-title":"Chem Phys Lipids"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652435414X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652435414X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.300.1.34","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:11:39Z","timestamp":1740006699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652435414X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S002235652435414X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.300.1.34","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Potent Emetogenic Effects of the Endocannabinoid, 2-AG (2-Arachidonoylglycerol) Are Blocked by \u03949-Tetrahydrocannabinol and Other Cannnabinoids","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.300.1.34","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2002 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}